Earlier studies have shown that polymorphisms of GAD2, which encodes an enzyme that catalyzes the production of gamma-aminobutyric acid (GABA), are associated with obesity, BMI, and postabsorptive resting energy expenditure in selected populations [10], [51], [52], [53], [54]. This evidence concerns the gene GAD2 and obesity disorder.